Search research articles
Contact Us
Filters
Showing results (51-60 of 64) with videos related to
Page
of 7
Sort By:
Journal of Medical Internet Research
|
September 6, 2024
Establishing Medical Intelligence-Leveraging Fast Healthcare Interoperability Resources to Improve Clinical Management: Retrospective Cohort and Clinical Implementation Study
Alexander Brehmer, Christopher Martin Sauer, Jayson Salazar Rodríguez, et al.
European Urology Open Science
|
July 23, 2025
Real-world Evidence from a Retrospective Multicentre Analysis on First-line Therapy for Metastatic Papillary Renal Cell Carcinoma. A GUARDIANS Project
Thomas Hilser, Jozefina Casuscelli, Can Aydogdu, et al.
World Journal of Urology
|
March 29, 2022
Variation across operating sites in urinary and sexual outcomes after radical prostatectomy in localized and locally advanced prostate cancer
Nora Tabea Sibert, Holger Pfaff, Clara Breidenbach, et al.
Minerva Urology and Nephrology
|
November 28, 2024
Robot-assisted partial nephrectomy of multiple tumors: a multicenter analysis
Pouriya Faraj Tabrizi, Philip Zeuschner, Olga Katzendorn, et al.
European Urology Open Science
|
July 13, 2023
Enfortumab Vedotin in Metastatic Urothelial Carcinoma: Survival and Safety in a European Multicenter Real-world Patient Cohort
Stefanie Zschäbitz, Nadine Biernath, Thomas Hilser, et al.
European Urology Oncology
|
June 3, 2023
Identification of the Optimal Candidates for Nodal Staging with Extended Pelvic Lymph Node Dissection Among Prostate Cancer Patients Who Underwent Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography. External Validation of the Memorial Sloan Kettering Cancer Center and Briganti Nomograms and Development of a Novel Tool
Giorgio Gandaglia, Francesco Barletta, Daniele Robesti, et al.
European Urology Oncology
|
September 9, 2023
Which Patients with Prostate Cancer and Lymph Node Uptake at Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography/Computerized Tomography Scan Are at a Higher Risk of Prostate-specific Antigen Persistence After Radical Prostatectomy? Identifying Indicators of Systemic Disease by Integrating Clinical, Magnetic Resonance Imaging, and Functional Imaging Parameters
Elio Mazzone, Giorgio Gandaglia, Daniele Robesti, et al.
European Urology Oncology
|
January 31, 2025
External Validation of Nomograms for the Identification of Pelvic Nodal Dissection Candidates Among Prostate Cancer Patients with Negative Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography
Giorgio Gandaglia, Francesco Barletta, Simone Scuderi, et al.
European Urology Oncology
|
December 6, 2025
Prostate-specific Membrane Antigen Positron Emission Tomography Versus Conventional Imaging for Preoperative Staging High-risk Prostate Cancer Patients Undergoing Surgery for cN0M0 Disease: An European Association of Urology-Young Academic Urologists Prostate Cancer Working Group Multi-institutional Study
Lorenzo Bianchi, Matteo Droghetti, Calogero Catanzaro, et al.
Cancer Immunology, Immunotherapy : CII
|
July 12, 2026
Effectiveness and safety of enfortumab vedotin and pembrolizumab in a real-world patient population with urothelial carcinoma: results from a multi-institutional cohort (GUARDIANS)
Stefanie Zschäbitz, Irfan Bhatti, Jozefina Casuscelli, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 64) with videos related to
Sort By:
Page
of 7
Journal of Medical Internet Research
|
September 6, 2024
Establishing Medical Intelligence-Leveraging Fast Healthcare Interoperability Resources to Improve Clinical Management: Retrospective Cohort and Clinical Implementation Study
Alexander Brehmer, Christopher Martin Sauer, Jayson Salazar Rodríguez, et al.
European Urology Open Science
|
July 23, 2025
Real-world Evidence from a Retrospective Multicentre Analysis on First-line Therapy for Metastatic Papillary Renal Cell Carcinoma. A GUARDIANS Project
Thomas Hilser, Jozefina Casuscelli, Can Aydogdu, et al.
World Journal of Urology
|
March 29, 2022
Variation across operating sites in urinary and sexual outcomes after radical prostatectomy in localized and locally advanced prostate cancer
Nora Tabea Sibert, Holger Pfaff, Clara Breidenbach, et al.
Minerva Urology and Nephrology
|
November 28, 2024
Robot-assisted partial nephrectomy of multiple tumors: a multicenter analysis
Pouriya Faraj Tabrizi, Philip Zeuschner, Olga Katzendorn, et al.
European Urology Open Science
|
July 13, 2023
Enfortumab Vedotin in Metastatic Urothelial Carcinoma: Survival and Safety in a European Multicenter Real-world Patient Cohort
Stefanie Zschäbitz, Nadine Biernath, Thomas Hilser, et al.
European Urology Oncology
|
June 3, 2023
Identification of the Optimal Candidates for Nodal Staging with Extended Pelvic Lymph Node Dissection Among Prostate Cancer Patients Who Underwent Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography. External Validation of the Memorial Sloan Kettering Cancer Center and Briganti Nomograms and Development of a Novel Tool
Giorgio Gandaglia, Francesco Barletta, Daniele Robesti, et al.
European Urology Oncology
|
September 9, 2023
Which Patients with Prostate Cancer and Lymph Node Uptake at Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography/Computerized Tomography Scan Are at a Higher Risk of Prostate-specific Antigen Persistence After Radical Prostatectomy? Identifying Indicators of Systemic Disease by Integrating Clinical, Magnetic Resonance Imaging, and Functional Imaging Parameters
Elio Mazzone, Giorgio Gandaglia, Daniele Robesti, et al.
European Urology Oncology
|
January 31, 2025
External Validation of Nomograms for the Identification of Pelvic Nodal Dissection Candidates Among Prostate Cancer Patients with Negative Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography
Giorgio Gandaglia, Francesco Barletta, Simone Scuderi, et al.
European Urology Oncology
|
December 6, 2025
Prostate-specific Membrane Antigen Positron Emission Tomography Versus Conventional Imaging for Preoperative Staging High-risk Prostate Cancer Patients Undergoing Surgery for cN0M0 Disease: An European Association of Urology-Young Academic Urologists Prostate Cancer Working Group Multi-institutional Study
Lorenzo Bianchi, Matteo Droghetti, Calogero Catanzaro, et al.
Cancer Immunology, Immunotherapy : CII
|
July 12, 2026
Effectiveness and safety of enfortumab vedotin and pembrolizumab in a real-world patient population with urothelial carcinoma: results from a multi-institutional cohort (GUARDIANS)
Stefanie Zschäbitz, Irfan Bhatti, Jozefina Casuscelli, et al.
Page
of 7